Fixed Competitive Price 1-Naphthalenecarboxylic Acid - 2-Methyl-4-Nitrobenzoic Acid CAS 1975-51-5 Tolvaptan Intermediate Factory High Quality – Ruifu

Short Description:

Product Detail

Product Tags

Feedback (2)

"Quality first, Honesty as base, Sincere service and mutual profit" is our idea, in order to develop continuously and pursue the excellence for COVID-19 Related Products, N"-Dicyclohexylcarbodiimide, Folic Acid, As an experienced group we also accept customized orders. The main goal of our company is to build up a satisfying memory for all customers, and establish a long-term win-win business relationship.

Fixed Competitive Price 1-Naphthalenecarboxylic Acid - 2-Methyl-4-Nitrobenzoic Acid CAS 1975-51-5 Tolvaptan Intermediate Factory High Quality – Ruifu Detail:

Manufacturer Supply High Quality, Commercial Production
Chemical Name: 2-Methyl-4-Nitrobenzoic Acid
CAS: 1975-51-5

Chemical Name	2-Methyl-4-Nitrobenzoic Acid
Synonyms	4-Nitro-o-Toluic Acid; 4-Nitro-2-Methylbenzoic Acid
CAS Number	1975-51-5
CAT Number	RF-PI397
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C8H7NO4
Molecular Weight	181.15
Brand	Ruifu Chemical

Item	Specifications
Appearance	Almost White or Pale Yellow Crystal Powder
1H-NMR	Consistent with Structure
Purity / Analysis Method	≥98.0% (HPLC)
Melting Point	153.0~156.0℃
Moisture (K.F)	≤0.50%
Residue on Ignition	≤0.50%
Total Impurities	≤2.0%
Test Standard	Enterprise Standard
Usage	Intermediate of Tolvaptan (CAS 150683-30-0)

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.

2-Methyl-4-Nitrobenzoic Acid (CAS 1975-51-5) is used as a pharmaceutical intermediate in the synthesis of Tolvaptan (CAS 150683-30-0). Tolvaptan is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28μM for the inhibition of AVP-induced platelet aggregation. Tolvaptan is used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH). Tolvaptan was approved by the U.S. Food and Drug Administration on May 19, 2009, and is sold by Otsuka Pharmaceutical Co. under the trade name Samsca.

Product detail pictures:

Related Product Guide:

It adheres on the tenet "Honest, industrious, enterprising, innovative" to develop new items frequently. It regards buyers, success as its very own success. Let us produce prosperous future hand in hand for Fixed Competitive Price 1-Naphthalenecarboxylic Acid - 2-Methyl-4-Nitrobenzoic Acid CAS 1975-51-5 Tolvaptan Intermediate Factory High Quality – Ruifu , The product will supply to all over the world, such as: Brunei, Albania, Moscow, To let customers be more confident in us and get the most comfortable service, we run our company with honesty, sincerity and best quality . We firmly believe that it is our pleasure to help customers to run their business more successfully, and that our experienced advice and service can lead to more suitable choice for the customers.